Researcher Profile

Keywords Cloud

KRIBB Co-Working

Results 1-20 of 39 (Search time: 0.002 seconds).

No. Year Title Type
39 2025

2025Article

Anti-proteolytic regulation of KRAS by USP9X/NDRG3 in KRAS-driven cancer developmentNature Communications, vol. 16, pp. 628-628Han Koo; Kyung Chan Park; Hyun Ahm Sohn; Minho Kang; D J Kim; Z Y Park; S Park; S H Min; Seong-Hwan Park; Yeon Mi You, et al.
Article
38 2025

2025Article

VHL-mediated SYT11 degradation suppresses gastric cancer cell growth and invasion through downregulation of SPINK1Journal of Cellular and Molecular Medicine, vol. 29, no. 13, pp. e70658-e70658Ji Su Yu; Mi Aie Hwang; Mi Sun Won; Joo-Young Im; D H Kweon; Y G Park; Bo Kyung Kim
Article
37 2024

2024Article

CYB5R3 functions as a tumor suppressor by inducing ER stress-mediated apoptosis in lung cancer cells via the PERK-ATF4 and IRE1α-JNK pathwaysExperimental and Molecular Medicine, vol. 56, no. 1, pp. 235-249Joo-Young Im; S J Kim; Jong Lyul Park; Tae Hee Han; Woo-Il Kim; Inhyub Kim; Bomin Ko; So-Young Chun; Mi-Jung KangBo Kyung Kim, et al.
Article
36 2023

2023Article

TNF-α secreted from macrophages increases the expression of prometastatic integrin αV in gastric cancerInternational Journal of Molecular Sciences, vol. 24, no. 1, pp. 376-376Mi Aie Hwang; Misun Won; Joo-Young ImMi-Jung Kang; D H Kweon; Bo Kyung Kim
Article
35 2023

2023Article

DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancerExperimental and Molecular Medicine, vol. 55, no. 5, pp. 879-885Joo-Young ImMi-Jung KangBo Kyung Kim; Mi Sun Won
Article
34 2022

2022Article

Synaptotagmin 11 scaffolds MKK7-JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesisJournal of Experimental & Clinical Cancer Research, vol. 41, pp. 212-212Bo Kyung Kim; Da Mi Kim; Hyunkyung Park; Seon-Kyu Kim; Mi Aie Hwang; Jungwoon LeeMi-Jung Kang; Jae Eun Byun; Joo-Young ImMinho Kang, et al.
Article
33 2022

2022Article

DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapyExperimental and Molecular Medicine, vol. 54, no. 8, pp. 1236-1249Haejeong Heo; Jong-Hwan Kim; Hyun Jung Lim; Jeong Hwan Kim; M Kim; J Koh; Joo-Young ImBo Kyung Kim; Mi Sun Won; Ji Hwan Park, et al.
Article
32 2021

2021Article

VGLL1 phosphorylation and activation promotes gastric cancer malignancy via TGF-β/ERK/RSK2 signalingBiochimica et Biophysica Acta-Molecular Cell Research, vol. 1868, pp. 118892-118892Joo-Young Im; Da Mi Kim; Hyunkyung Park; Mi-Jung Kang; Da Yoon Kijm; K Y Chang; Bo Kyung Kim; Mi Sun Won
Article
31 2021

2021Article

DGG-100629 inhibits lung cancer growth by suppressing the NFATc1/DDIAS/STAT3 pathwayExperimental and Molecular Medicine, vol. 53, no. 4, pp. 643-653Joo-Young ImBo Kyung Kim; S H Yoon; B C Cho; Y M Baek; Mi-Jung Kang; N Kim; Y D Gong; Mi Sun Won
Article
30 2021

2021Article

Targeting HSF1 as a therapeutic strategy for multiple mechanisms of EGFR inhibitor resistance in EGFR mutant non-small-cell lung cancer = 활성 EGFR 발현 비소세포 폐암의 EGFR 표적항암제에 대한 다중 내성 치료표적으로의 HSF1Cancers, vol. 13, no. 12, pp. 2987-2987Sangah Lee; JiYae Jung; Yu-Jin LeeSeon-Kyu KimJung Ae KimBo Kyung KimKyung Chan Park; Byoung-Mog Kwon; Dong Cho Han
Article
29 2020

2020Article

The disubstituted adamantyl derivative LW1564 inhibits the growth of cancer cells by targeting mitochondrial respiration and reducing hypoxia-inducible factor (HIF)-1α accumulationExperimental and Molecular Medicine, vol. 52, no. 11, pp. 1845-1856Inhyub Kim; M Kim; Min Kyung Park; R Naik; J H Park; Bo Kyung Kim; Y Choi; K Y Chang; Mi Sun Won; Hyun Seung Ban, et al.
Article
28 2020

2020Article

Miconazole inhibits signal transducer and activator of transcription 3 signaling by preventing its interaction with DNA damage-induced apoptosis suppressorCancer Science, vol. 111, no. 7, pp. 2499-2507Sung Hoon Yoon; Bo Kyung KimMi-Jung KangJoo-Young Im; Mi Sun Won
Article
27 2020

2020Article

DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cellsOncogenesis, vol. 9, pp. 1-1Joo-Young ImBo Kyung Kim; K W Lee; So-Young Chun; Mi-Jung Kang; Mi Sun Won
Article
26 2019

2019Article

PI3K/AKT/β-catenin signaling regulates vestigial-like 1 which predicts poor prognosis and enhances malignant phenotype in gastric cancer = PI3K/AKT/β-catenin 신호전달이 위암 악성화에 관여하는 VGLL1 조절에 기여Cancers, vol. 11, pp. 1923-1923Bo Kyung Kim; J H Cheong; Joo-Young ImHyun Seung BanSeon-Kyu KimMi-Jung KangJungwoon LeeSeon-Young KimKyung Chan Park; S Paik, et al.
Article
25 2018

2018Article

DDIAS suppresses TRAIL-mediated apoptosis by inhibiting DISC formation and destabilizing caspase-8 in cancer cellsOncogene, vol. 37, pp. 1251-1262Joo-Young ImBo Kyung Kim; Ji Young Lee; Seung Ho Park; Hyun Seung Ban; K E Jung; Mi Sun Won
Article
24 2018

2018Article

RNF25 promotes gefitinib resistance in EGFR-mutant NSCLC cells by inducing NF-κB-mediated ERK reactivationCell Death & Disease, vol. 9, no. 6, pp. 587-587Jung Hee Cho; Yeon Mi You; Young Il Yeom; Dong Chul LeeBo Kyung Kim; Mi Sun Won; B C Cho; Mingho Kang; Seulki Park; Suk-Jin Yang, et al.
Article
23 2018

2018Article

Bcl-2-dependent synthetic lethal interaction of the IDF-11774 with the V0 subunit C of vacuolar ATPase (ATP6V0C) in colorectal cancer = 대장암에서의 Bcl-2-의존적인 IDF-11774와 ATP6V0C 합성치사British Journal of Cancer, vol. 119, no. 11, pp. 1347-1357Bo Kyung Kim; S W Nam; B S Min; Hyun Seung Ban; S Paik; K Lee; Joo-Young Im; Youngjoo Lee; J T Park; Seon-Young Kim, et al.
Article
22 2017

2017Article

Stability of the cancer target DDIAS is regulated by the CHIP/HSP70 pathway in lung cancer cellsCell Death & Disease, vol. 8, no. 1, pp. e2554-e2554Kyoung Jae Won; Joo-Young ImBo Kyung KimHyun Seung Ban; Young Jin Jung; K E Jung; Mi Sun Won
Article
21 2017

2017Article

The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growthCell Death & Disease, vol. 8, no. 6, pp. e2843-e2843Hyun Seung BanBo Kyung Kim; H Lee; H M Kim; D Harmalkar; M Nam; S K Park; K Lee; J T Park; In Hyub Kim, et al.
Article
20 2017

2017Article

Methyl 3-(3-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a novel and dual malate dehydrogenase (MDH) 1/2 inhibitor targeting cancer metabolismJournal of Medicinal Chemistry, vol. 60, no. 20, pp. 8631-8646R Naik; Hyun Seung Ban; K Jang; I Kim; X Xu; D Harmalkar; S A Shin; M Kim; Bo Kyung Kim; J Park, et al.
Article
1 2